Over the past couple of years, the engineered biology market has seen fledgling companies rise to IPO smashing power players, as the demand for high-quality, engineered biomolecules and controllable therapeutics grows exponentially.

The therapeutic potential of novel synthetic units is huge, but challenges remain in demonstrating proof-of-concept, developing assays, functional characterization, manufacturing scale-up, and identifying therapeutic applications for commercial development.

Returning for the 2nd year, the Synthetic Biology-Based Therapies Summit is the industry-defining forum made exclusively for leaders in the synthetic and engineered biology space, focusing on the technical challenges that lie ahead in the path towards commercialization.

Learn from industry trailblazers at Arsenal Biosciences, bit.bio, MIT, Novome Bio, Strand Therapeutics, Synlogic and more, to support your efforts in developing safe and effective synthetic biology-based therapeutics.

Prices:

Conference + Workshop Day - Industry Pricing USD 3497.00

Conference Only - Industry Pricing USD 2599.00

Conference + Workshop Day - Service Provider Pricing USD 4297.00

Conference Only - Service Provider Pricing USD 3199.00

Conference + Workshop Day - Academic Pricing USD 2897.00

Conference Only - Academic Pricing USD 2199.00

Category: Conferences | Science, Health & Medicine | Pharmaceuticals | Drug Development

Dates and Time: Starts: Tue, Dec 13, 2022 ( 9:00 AM) and Ends: Thu, Dec 15, 2022 ( 5:00 PM)

Venue details: Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street, Boston, Massachusetts, 02128, United States

Continue reading at synthetic-biology-therapeutics-summit.com

Biosimilar Pharmaceuticals

Facebook Share

Twitter Share

Linkedin Share

Email Share